TMCnet - World's Largest Communications and Technology Community

TMCNet:  NanoLogix and Saudi Company To Work Together for Distribution of NanoLogix Products in the Arabian Gulf Region

[December 04, 2013]

NanoLogix and Saudi Company To Work Together for Distribution of NanoLogix Products in the Arabian Gulf Region

HUBBARD, Ohio --(Business Wire)--

NanoLogix, Inc. (NNLX), an innovator in the rapid detection, identification of live bacteria, and determination of their antibiotic resistance and sensitivity, announces that they are working with Nasaem-Aljazira, a Saudi Arabian company headquartered in Riyadh, to establish exclusive distribution and/or manufacturing of NanoLogix products in Saudi Arabia and the Arabian Gulf region, also known as the Gulf Cooperation Council (GCC) area.

This area offers a large market potential to Nasaem-Aljazira and NanoLogix, with Saudi Arabia being a leader in advanced health care initiatives for its people.

NanoLogix is also in negotiations with groups and companies in Europe, Asia and Africa on additional distribution outlets and manufacturing options.

The Company currently sells and ships its products in the US and to the UK.

In keeping with NanoLogix' policy of continual product improvement, the Company has begun electron beam (e-Beam) processing of the majority of its filled Petri plate and BNP detection kit FlatPacks through the facilities at Synergy (News - Alert) HealthAST. htp://

This process was initiated to ensure that our FlatPack preserved Petri plates and BNP kits remain viable throughout their extended shelf life, which in some cases for common agars have now exceeded one year at room temperature and two years in cold storage. These times are in sharp contrast with the 3-4 months of shelf life available with competitor's products and offer a significant economic advantage to customers with limited or no cold storage capacity, or those with dynamic testing and project schedules.

NanoLogix recently added 13 additional product variants that have been in demand by its customers and has improved its ordering procedure, enabling a "mix and match" capability for ordering that allows customers to order up to ten different Flatpack detection products in one single carton.

NanoLogix and researchers at UTHSC Houston are working to finalize development of the Company's new N-Assay detection and identification assay. The original concept for use with one bacteria has expanded to one in which as many as five different pathogens can be rapidly detected, identified, and analyzed for antibiotic sensitivity or resistance on one N-Assay multiwell microplate.

About NanoLogix, Inc.

NanoLogix is a biotechnology company focused primarily on rapid diagnostics. Its products offer accelerated detection and identification of microorganisms. In addition to medical, National Defense, and homeland security applications, NanoLogix technology is applicable in pharmaceutical, industrial, veterinary and environmental testing.

Patents granted to NanoLogix can be used in the areas of applied microbiology, soil microbiology and bioremediation, microbial physiology, molecular biology, pharmacology, pharmaco-kinetics, and antibiotic sensitivity

For more information visit

This press release contains statements, which may constitute "forward- looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of NanoLogix, Inc., and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

[ Back To Technology News's Homepage ]


Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2014 Technology Marketing Corporation. All rights reserved.